Ayala Pharmaceuticals, Advaxis to Combine in Stock Deal >AYLA ADXS
marketwatch.com
news
2022-10-19 10:51:00

By Colin Kellaher Cancer-focused biotechnology companies Ayala Pharmaceuticals Inc. and Advaxis Inc. on Wednesday said they have agreed to combine in a stock swap. According to the companies, shareholders of Rehovot, Israel-based Ayala would receive Advaxis shares representing about 62.5% of the combined company, while shareholders of Advaxis, based in Monmouth Junction, N.J., would continue to own roughly 37.5%. Based on Tuesday's closing prices, Ayala has a market capitalization of around $13.7 million, while Advaxis sports a market capitalization of about $4.
